Development of nonhuman adenoviruses as vaccine vectors

Vaccine

Volumn 24, Issue 7, 2006, Pages 849-862

  Bangari, Dinesh S ^a   Mittal, Suresh K ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Adenoviral vector immunity; Adenoviral vector based vaccine; Adenoviral vectors; Nonhuman adenoviral vectors

Indexed keywords

ADENOVIRUS VECTOR; VIRUS VACCINE;

ANTIGEN EXPRESSION; BOVINE ADENOVIRUS; CHICK EMBRYO LETHAL ORPHAN VIRUS; CHIMPANZEE; CLINICAL TRIAL; DOG; DRUG DESIGN; DRUG EFFICACY; DRUG INACTIVATION; DRUG MECHANISM; DRUG SAFETY; GENE INSERTION; HUMAN; HUMAN ADENOVIRUS; IMMUNIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PORCINE ADENOVIRUS; PRIORITY JOURNAL; REVIEW; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; GENETIC VECTORS; HUMANS; IMMUNIZATION; VACCINES, SYNTHETIC;

EID: 31844448804     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.101     Document Type: Review

References (134)

1. F.L. Graham Adenoviruses as expression vectors and recombinant vaccines Trends Biotechnol 8 4 1990 85 87
2. J.L. Imler Adenovirus vectors as recombinant viral vaccines Vaccine 13 13 1995 1143 1151
3. O.K. Yarosh, A.I. Wandeler, F.L. Graham, J.B. Campbell, and L. Prevec Human adenovirus type 5 vectors expressing rabies glycoprotein Vaccine 14 13 1996 1257 1264
4. N. Tatsis, and H.C. Ertl Adenoviruses as vaccine vectors Mol Ther 10 4 2004 616 629
5. W.C. Russell Update on adenovirus and its vectors J Gen Virol 81 Part 11 2000 2573 2604
6. H. Kasuya, S. Takeda, S. Nomoto, and A. Nakao The potential of oncolytic virus therapy for pancreatic cancer Cancer Gene Ther 12 9 2005 725 736
7. E.A. Chiocca, K.M. Abbed, S. Tatter, D.N. Louis, F.H. Hochberg, and F. Barker A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting Mol Ther 10 5 2004 958 966
8. E. Galanis, S.H. Okuno, A.G. Nascimento, B.D. Lewis, R.A. Lee, and A.M. Oliveira Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas Gene Ther 12 5 2005 437 445
9. J.A. Howe, R. Ralston, and M. Ramachandra Development of oncolytic adenoviruses: from the lab bench to the bedside D.T. Curiel J.T. Douglas Cancer gene therapy 2005 Humana Press Totowa 211 234
10. D.R. Shaw, and A.F. LoBuglio Genetic immunotherapy approaches D.T. Curiel J.T. Douglas Cancer gene therapy 2005 Humana Press Totowa 129 142
11. F.H. Top Jr., R.A. Grossman, P.J. Bartelloni, H.E. Segal, B.A. Dudding, and P.K. Russell Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans J Infect Dis 124 2 1971 148 154
12. Z.Q. Xiang, Y. Yang, J.M. Wilson, and H.C. Ertl A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier Virology 219 l 1996 220 227
13. J.C. Fitzgerald, G.P. Gao, A. Reyes-Sandoval, G.N. Pavlakis, Z.Q. Xiang, and A.P. Wlazlo A simian replication-defective adenoviral recombinant vaccine to FIV-1 gag J Immunol 170 3 2003 1416 1422
14. A.R. Pinto, J.C. Fitzgerald, W. Giles-Davis, G.P. Gao, J.M. Wilson, and H.C. Ertl Induction of CD8+T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers J Immunol 171 12 2003 6774 6779
15. Y. Zhang, N. Chirmule, G.P. Gao, R. Qian, M. Croyle, and B. Joshi Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages Mol Ther 3 5 2001 697 707
16. N.J. Philpott, M. Nociari, K.B. Elkon, and E. Falck-Pedersen Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway Proc Nati Acad Sci USA 101 16 2004 6200 6205
17. M.L. Edelstein, M.R. Abedi, J. Wixon, and R.M. Edelstein Gene therapy clinical trials worldwide 1989-2004 - an overview J Gene Med 6 6 2004 597 602
18. J.W. Shiver, and E.A. Emini Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors Annu Rev Med 55 2004 355 372
19. D.H. Barouch, and G.J. Nabel Adenovirus vector-based vaccines for human immunodeficiency virus type 1 Hum Gene Ther 16 2 2005 149 156
20. N.J. Sullivan, T.W. Geisbert, J.B. Geisbert, L. Xu, Z.Y. Yang, and M. Roederer Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates Nature 424 6949 2003 681 684
21. J.R. Mascola, A. Sambor, K. Beaudry, S. Santra, B. Welcher, and M.K. Louder Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins J Virol 79 2 2005 771 779
22. M.S. Seaman, L. Xu, K. Beaudry, K.L. Martin, M.H. Beddall, and A. Miura Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys J Virol 79 5 2005 2956 2963
23. D.R. Casimiro, A. Tang, L. Chen, T.M. Fu, R.K. Evans, and M.E. Davies Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene J Virol 77 13 2003 7663 7668
24. D.R. Casimiro, L. Chen, T.M. Fu, R.K. Evans, M.J. Caulfield, and M.E. Davies Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene J Virol 77 11 2003 6305 6313
25. K. Kasuya, J.L. Boyer, Y. Tan, D.O. Alipui, N.R. Hackett, and R.G. Crystal Passive immunotherapy for anthrax toxin mediated by an adenovirus expressing an anti-protective antigen single-chain antibody Mol Ther 11 2 2005 237 244
26. Y. Tan, N.R. Hackett, J.L. Boyer, and R.G. Crystal Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen Hum Gene Ther 14 17 2003 1673 1682
27. W. Gao, A. Tamin, A. Soloff, L. D'Aiuto, E. Nwanegbo, and P.D. Robbins Effects of a SARS-associated coronavirus vaccine in monkeys Lancet 362 9399 2003 1895 1896
28. R. Vogels, D. Zuijdgeest, R.R. van, E. Hartkoorn, I. Damen, and M.P. de Bethune Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity J Virol 77 15 2003 8263 8271
29. E. Nwanegbo, E. Vardas, W. Gao, H. Whittle, H. Sun, and D. Rowe Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States Clin Diagn Lab Immunol 11 2 2004 351 357
30. Y. Yang, Q. Li, H.C. Ertl, and J.M. Wilson Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses J Virol 69 4 1995 2004 2015
31. V. Molinier-Frenkel, H. Gahery-Segard, M. Mehtali, B.C. Le, S. Ribault, and P. Boulanger Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes J Virol 74 16 2000 7678 7682
32. C.I. Toogood, J. Crompton, and R.T. Hay Antipeptide antisera define neutralizing epitopes on the adenovirus hexon J Gen Virol 73 1992 1429 1435
33. S.M. Sumida, D.M. Truitt, M.G. Kishko, J.C. Arthur, S.S. Jackson, and D.A. Gorgone Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors J Virol 78 6 2004 2666 2673
34. S.K. Mittal, M.R. McDermott, D.C. Johnson, L. Prevec, and F.L. Graham Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter Virus Res 28 l 1993 67 90
35. N. Chirmule, S.E. Raper, L. Burkly, D. Thomas, J. Tazelaar, and J.V. Hughes Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40-CD40 ligand interactions J Virol 74 7 2000 3345 3352
36. S. Moffatt, J. Hays, H. HogenEsch, and S.K. Mittal Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy Virology 272 l 2000 159 167
37. D.H. Barouch, P.F. McKay, S.M. Sumida, S. Santra, S.S. Jackson, and D.A. Gorgone Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines J Virol 77 16 2003 8729 8735
38. Z.Y. Yang, L.S. Wyatt, W.P. Kong, Z. Moodie, B. Moss, and G.J. Nabel Overcoming immunity to a viral vaccine by DNA priming before vector boosting J Virol 77 1 2003 799 803
39. Z. Xiang, Y. Li, G. Gao, J.M. Wilson, and H.C. Ertl Mucosally delivered E1-deleted adenoviral vaccine carriers induce transgene product-specific antibody responses in neonatal mice J Immunol 171 8 2003 4287 4293
40. M.A. Croyle, N. Chirmule, Y. Zhang, and J.M. Wilson PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver Hum Gene Ther 13 15 2002 1887 1900
41. G. Sailaja, H. HogenEsch, A. North, J. Hays, and S.K. Mittal Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response Gene Ther 9 24 2002 1722 1729
42. R. Youil, T.J. Toner, Q. Su, D. Casimiro, J.W. Shiver, and L. Chen Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenoviruses Hum Gene Ther 14 10 2003 1017 1034
43. J.G. Gall, R.G. Crystal, and E. Falck-Pedersen Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype J Virol 72 12 1998 10260 10264
44. M.J. Havenga, A.A. Lemckert, J.M. Grimbergen, R. Vogels, L.G. Huisman, and D. Valerio Improved adenovirus vectors for infection of cardiovascular tissues J Virol 75 7 2001 3335 3342
45. L. Holterman, R. Vogels, V. van d, M. Sieuwerts, J. Grimbergen, and J. Kaspers Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5 J Virol 78 23 2004 13207 13215
46. S.F. Farina, G.P. Gao, Z.Q. Xiang, J.J. Rux, R.M. Burnett, and M.R. Alvira Replication-defective vector based on a chimpanzee adenovirus J Virol 75 23 2001 11603 11613
47. J.N. Glasgow, E.J. Kremer, A. Hemminki, G.P. Siegal, J.T. Douglas, and D.T. Curiel An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism Virology 324 1 2004 103 116
48. D.S. Bangari, and S.K. Mittal Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in culture Virus Res 105 2 2004 127 136
49. C. Hofmann, P. Loser, G. Cichon, W. Arnold, G.W. Both, and M. Strauss Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo J Virol 73 8 1999 6930 6936
50. A.J. Davison, M. Benko, and B. Harrach Genetic content and evolution of adenoviruses J Gen Virol 84 2003 2895 2908
51. C. Büchen-Osmond Adenoviridae. In: ICTVdB - The Universal Virus Database, version 3, ICTVdB Management, The Earth Institute and Department of Epidemiology, Mailman School of Public Health 2003 Columbia University New York, NY, USA 00.001
52. E.J. Kremer, S. Boutin, M. Chillon, and O. Danos Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer J Virol 74 1 2000 505 512
53. A.L. van Olphen, and S.K. Mittal Generation of infectious genome of bovine adenovirus type 3 by homologous recombination in bacteria J Virol Meth 77 2 1999 125 129
54. U.B. Rasmussen, M. Benchaibi, V. Meyer, Y. Schlesinger, and K. Schughart Novel human gene transfer vectors: evaluation of wild-type and recombinant animal adenoviruses in human-derived cells Hum Gene Ther 10 16 1999 2587 2599
55. A. Zakhartchouk, Y. Zhou, and S.K. Tikoo A recombinant E1-deleted porcine adenovirus-3 as an expression vector Virology 313 2 2003 377 386
56. D.S. Bangari, S. Shukla, and S.K. Mittal Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture Biochem Biophys Res Commun 327 3 2005 960 966
57. J.H. Darbyshire, P.S. Dawson, P.H. Lamont, D.C. Ostler, and H.G. Pereira A new adenovirus serotype of bovine origin J Comp Pathol 75 3 1965 327 330
58. P.S. Reddy, N. Idamakanti, A.N. Zakhartchouk, M.K. Baxi, J.B. Lee, and C. Pyne Nucleotide sequence, genome organization, and transcription map of bovine adenovirus type 3 J Virol 72 2 1998 1394 1402
59. S.K. Mittal, L. Prevec, F.L. Graham, and L.A. Babiuk Development of a bovine adenovirus type 3-based expression vector J Gen Virol 76 1995 93 102
60. L. Zhang, S. Gomis, and S.K. Tikoo Evaluation of promoters for foreign gene expression in the E3 region of bovine adenovirus type-3 Virus Res 110 1-2 2005 169 176
61. F.L. Graham, J. Smiley, W.C. Russell, and R. Nairn Characteristics of a human cell line transformed by DNA from human adenovirus type 5 J Gen Virol 36 1 1977 59 74
62. B. Zheng, S.K. Mittal, F.L. Graham, and L. Prevec The E1 sequence of bovine adenovirus type 3 and complementation of human adenovirus type 5 E1 A function in bovine cells Virus Res 31 2 1994 163 186
63. P.S. Reddy, N. Idamakanti, Y. Chen, T. Whale, L.A. Babiuk, and M. Mehtali Replication-defective bovine adenovirus type 3 as an expression vector J Virol 73 11 1999 9137 9144
64. A.L. van Olphen, S.K. Tikoo, and S.K. Mittal Characterization of bovine adenovirus type 3 E1 proteins and isolation of E1-expressing cell lines Virology 295 1 2002 108 118
65. L. Xing, L. Zhang, K.J. Van, and S.K. Tikoo Identification of cis-acting sequences required for selective packaging of bovine adenovirus type 3 DNA J Gen Virol 84 2003 2947 2956
66. A. Zakhartchouk, W. Connors, K.A. van, and S.K. Tikoo Bovine adenovirus type 3 containing heterologous protein in the C-terminus of minor capsid protein IX Virology 320 2 2004 291 300
67. A.N. Zakhartchouk, C. Pyne, G.K. Mutwiri, Z. Papp, M.E. Baca-Estrada, and P. Griebel Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1 J Gen Virol 80 1999 1263 1269
68. P.S. Reddy, N. Idamakanti, C. Pyne, A.N. Zakhartchouk, D.L. Godson, and Z. Papp The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle Vet Immunol Immunopathol 76 3-4 2000 257 268
69. M.K. Baxi, D. Deregt, J. Robertson, L.A. Babiuk, T. Schlapp, and S.K. Tikoo Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats Virology 278 1 2000 234 243
70. S.K. Mittal, S.K. Tikoo, J. Van Donkersgoed, T. Beskorwayne, D.L. Godson, and L.A. Babiuk Experimental inoculation of heifers with bovine adenovirus type 3 Can J Vet Res 63 2 1999 153 156
71. D.S. Bangari, A. Sharma, and S.K. Mittal Bovine adenovirus type 3 internalization is independent of primary receptors of human adenovirus type 5 and porcine adenovirus type 3 Biochem Biophys Res Commun 331 4 2005 1478 1484
72. Q. Wu, and S.K. Tikoo Altered tropism of recombinant bovine adenovirus type-3 expressing chimenc fiber Virus Res 99 l 2004 9 15
73. M.D. Morrison, D.E. Onions, and L. Nicolson Complete DNA sequence of canine adenovirus type 1 J Gen Virol 78 Part 4 1997 873 878
74. M.D. Morrison, D. Reid, D. Onions, N. Spibey, and L. Nicolson Generation of E3-deleted canine adenoviruses expressing canine parvovirus capsid by homologous recombination in bacteria Virology 293 1 2002 26 30
75. B. Klonjkowski, P. Gilardi-Hebenstreit, J. Hadchouel, V. Randrianarison, S. Boutin, and P. Yeh A recombinant El-deleted canine adenoviral vector capable of transduction and expression of a transgene in human-derived cells and in vivo Hum Gene Ther 8 17 1997 2103 2115
76. A. Hemminki, A. Kanerva, E.J. Kremer, G.J. Bauerschmitz, B.F. Smith, and B. Liu A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model Mol Ther 7 2 2003 163 173
77. C. Soudais, S. Boutin, and E.J. Kremer Characterization of cis-acting sequences involved in canine adenovirus packaging Mol Ther 3 4 2001 631 640
78. C. Soudais, N. Skander, and E.J. Kremer Long-term in vivo transduction of neurons throughout the rat CNS using novel helper-dependent CAV-2 vectors FASEB J 18 2 2004 391 393
79. L. Fischer, J.P. Tronel, C. Pardo-David, P. Tanner, G. Colombet, and J. Minke Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge Vaccine 20 29-30 2002 3485 3497
80. C. Soudais, S. Boutin, S.S. Hong, M. Chillon, O. Danos, and J.M. Bergelson Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway J Virol 74 22 2000 10639 10649
81. C. Soudais, C. Laplace-Builhe, K. Kissa, and E.J. Kremer Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo FASEB J 15 12 2001 2283 2285
82. S. Roy, G. Gao, D.S. Clawson, L.H. Vandenberghe, S.F. Farina, and J.M. Wilson Complete nucleotide sequences and genome organization of four chimpanzee adenoviruses Virology 324 2 2004 361 372
83. S. Roy, G. Gao, Y. Lu, X. Zhou, M. Lock, and R. Calcedo Characterization of a family of chimpanzee adenoviruses and development of molecular clones for gene transfer vectors Hum Gene Ther 15 5 2004 519 530
84. Z. Xiang, G. Gao, A. Reyes-Sandoval, C.J. Cohen, Y. Li, and J.M. Bergelson Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product J Virol 76 6 2002 2667 2675
85. J.W. Shiver, T.M. Fu, L. Chen, D.R. Casimiro, M.E. Davies, and R.K. Evans Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity Nature 415 6869 2002 331 335
86. A. Reyes-Sandoval, J.C. Fitzgerald, R. Grant, S. Roy, Z.Q. Xiang, and Y. Li Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes J Virol 78 14 2004 7392 7399
87. H.C.J. Ertl Immunological insights from genetic vaccines Virus Res 111 l 2005 89 92
88. C.J. Cohen, Z.Q. Xiang, G.P. Gao, H.C. Ertl, J.M. Wilson, and J.M. Bergelson Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor J Gen Virol 83 2002 151 155
89. S. Vrati, E.S. MacAvoy, Z.Z. Xu, C. Smole, D.B. Boyle, and G.W. Both Construction and transfection of ovine adenovirus genomic clones to rescue modified viruses Virology 220 1 1996 200 203
90. M. Benko, and B. Harrach A proposal for a new (third) genus within the family Adenoviridae Arch Virol 143 4 1998 829 837
91. S. Vrati, D.E. Brookes, P. Strike, A. Khatri, D.B. Boyle, and G.W. Both Unique genome arrangement of an ovine adenovirus: identification of new proteins and proteinase cleavage sites Virology 220 1 1996 186 199
92. P. Loser, C. Hofmann, G.W. Both, W. Uckert, and M. Hillgenberg Construction, rescue, and characterization of vectors derived from ovine atadenovirus J Virol 77 22 2003 11941 11951
93. G.W. Both Ovine atadenovirus: a review of its biology, biosafety profile and application as a gene delivery vector Immunol Cell Biol 82 2 2004 189 195
94. A. Venktesh, F. Watt, Z.Z. Xu, and G.W. Both Ovine adenovirus (OAV287) lacks a virus-associated RNA gene J Gen Virol 79 Part 3 1999 509 516
95. A. Khatri, Z.Z. Xu, and G.W. Both Gene expression by atypical recombinant ovine adenovirus vectors during abortive infection of human and animal cells in vitro Virology 239 l 1997 226 237
96. T. Wuest, G.W. Both, A.M. Prince, C. Hofmann, and P. Loser Recombinant ovine atadenovirus induces a strong and sustained T cell response against the hepatitis C virus NS3 antigen in mice Vaccine 22 21-22 2004 2717 2721
97. P. Loser, M. Hillgenberg, W. Arnold, G.W. Both, and C. Hofmann Ovine adenovirus vectors mediate efficient gene transfer to skeletal muscle Gene Ther 7 17 2000 1491 1498
98. J.S. Rothel, D.B. Boyle, G.W. Both, A.D. Pye, J.G. Waterkeyn, and P.R. Wood Sequential nucleic acid and recombinant adenovirus vaccination induces host-protective immune responses against Taenia ovis infection in sheep Parasite Immunol 19 5 1997 221 227
99. D. Voeks, R. Martiniello-Wilks, V. Madden, K. Smith, E. Bennetts, and G.W. Both Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models Gene Ther 9 12 2002 759 768
100. R. Martiniello-Wilks, A. Dane, D.J. Voeks, G. Jeyakumar, E. Mortensen, and J.M. Shaw Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease J Gene Med 6 1 2004 43 54
101. D. Kumin, C. Hofmann, M. Rudolph, G.W. Both, and P. Loser Biology of ovine adenovirus infection of nonpermissive cells J Virol 76 21 2002 10882 10893
102. Z.Z. Xu, and G.W. Both Altered tropism of an ovine adenovirus carrying the fiber protein cell binding domain of human adenovirus type 5 Virology 248 1 1998 156 163
103. P.S. Reddy, N. Idamakanti, J.Y. Song, J.B. Lee, B.H. Hyun, and J.H. Park Nucleotide sequence and transcription map of porcine adenovirus type 3 Virology 251 2 1998 414 426
104. P.S. Reddy, N. Idamakanti, B.H. Hyun, S.K. Tikoo, and L.A. Babiuk Development of porcine adenovirus-3 as an expression vector J Gen Virol 80 1999 563 570
105. T. Tuboly, E. Nagy, and J.B. Derbyshire Potential viral vectors for the stimulation of mucosal antibody responses against enteric viral antigens in pigs Res Vet Sci 54 3 1993 345 350
106. J.M. Hammond, R.J. McCoy, E.S. Jansen, C.J. Morrissy, A.L. Hodgson, and M.A. Johnson Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever Vaccine 18 11-12 2000 1040 1050
107. J.M. Hammond, E.S. Jansen, C.J. Morrissy, H.B. van der, W.V. Goff, and M.M. Williamson Vaccination of pigs with a recombinant porcine adenovirus expressing the gD gene from pseudorabies virus Vaccine 19 27 2001 3752 3758
108. P.S. Reddy, N. Idamakanti, L.A. Babiuk, M. Mehtali, and S.K. Tikoo Porcine adenovirus-3 as a helper-dependent expression vector J Gen Virol 80 Part 11 1999 2909 2916
109. J.B. Derbyshire The interferon sensitivity of selected porcine viruses Can J Vet Res 53 1 1989 52 55
110. M. Nagy, and T. Tuboly Porcine adenoviruses: an update on genome analysis and vector development Acta Vet Hung 48 4 2000 491 499
111. J.M. Hammond, and M.A. Johnson Porcine adenovirus as a delivery system for swine vaccines and immunotherapeutics Vet J 169 l 2005 17 27
112. D.S. Bangari, and S.K. Mittal Porcine adenovirus serotype 3 internalization is independent of CAR and alpha(v)beta(3) or alpha(v)beta(5) integrin Virology 332 1 2005 157 166
113. T. Hirahara, H. Yasuhara, O. Matsui, M. Yamanaka, M. Tanaka, and S. Fukuyama Isolation of porcine adenovirus from the respiratory tract of pigs in Japan Nippon Juigaku Zasshi 52 2 1990 407 409
114. M. Nagy, E. Nagy, and T. Tuboly The complete nucleotide sequence of porcine adenovirus serotype 5 J Gen Virol 8 2001 525 529
115. T. Tuboly, and E. Nagy Construction and characterization of recombinant porcine adenovirus serotype 5 expressing the transmissible gastroenteritis virus spike gene J Gen Virol 82 2001 183 190
116. T. Tuboly, and E. Nagy Sequence analysis and deletion of porcine adenovirus serotype 5 E3 region Virus Res 68 2 2000 109 117
117. G. Meulemans, B. Couvreur, M. Decaesstecker, M. Boschmans, and T.P. Van Den Berg Phylogenetic analysis of fowl adenoviruses Avian Pathol 33 2 2004 164 170
118. V.J. Yates, Y.O. Rhee, D.E. Fry, A.M. El Mishad, and K.J. McCormick The presence of avian adenoviruses and adeno-assodated viruses in healthy chickens Avian Dis 20 1 1976 146 152
119. S. Chiocca, R. Kurzbauer, G. Schaffner, A. Baker, V. Mautner, and M. Cotten The complete DNA sequence and genomic organization of the avian adenovirus CELO J Virol 70 5 1996 2939 2949
120. P. Li, A.J. Bellett, and C.R. Parish Structural organization and polypeptide composition of the avian adenovirus core J Virol 52 2 1984 638 649
121. B.B. Asch, K.J. McCormick, W.A. Stenback, and J.J. Trentin Virus-specific markers and virus-like particles in cell lines of tumors produced by CELO virus in Syrian golden hamsters J Natl Cancer Inst 61 1 1978 163 171
122. P.S. Sarma, R.J. Huebner, and W.T. Lane Induction of tumors in hamsters with an avian adenovirus (CELO) Science 149 688 1965 1108
123. S. Chiocca, A. Baker, and M. Cotten Identification of a novel antiapoptotic protein, GAM-1, encoded by the CELO adenovirus J Virol 71 4 1997 3168 3177
124. H. Lehrmann, and M. Cotten Characterization of CELO virus proteins that modulate the pRb/E2F pathway J Virol 73 8 1999 6517 6525
125. J.B. Glotzer, M. Saltik, S. Chiocca, A.I. Michou, P. Moseley, and M. Cotten Activation of heat-shock response by an adenovirus is essential for virus replication Nature 407 6801 2000 207 211
126. A.I. Michou, H. Lehrmann, M. Saltik, and M. Cotten Mutational analysis of the avian adenovirus CELO, which provides a basis for gene delivery vectors J Virol 73 2 1999 1399 1410
127. A. Francois, N. Eterradossi, B. Delmas, V. Payet, and P. Langlois Construction of avian adenovirus CELO recombinants in cosmids J Virol 75 11 2001 5288 5301
128. A. Francois, C. Chevalier, B. Delmas, N. Eterradossi, D. Toquin, and G. Rivallan Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens Vaccine 22 17-18 2004 2351 2360
129. E.V. Shashkova, L.V. Cherenova, D.B. Kazansky, and K. Doronin Avian adenovirus vector CELO-TK displays anticancer activity in human cancer cells and suppresses established murine melanoma tumors Cancer Gene Ther 12 7 2005 617 626
130. M.A. Johnson, C. Pooley, J. Ignjatovic, and S.G. Tyack A recombinant fowl adenovirus expressing the S1 gene of infectious bronchitis virus protects against challenge with infectious bronchitis virus Vaccine 21 21-22 2003 2730 2736
131. M.A. Johnson, C. Pooley, and J.W. Lowenthal Delivery of avian cytokines by adenovirus vectors Dev Comp Immunol 24 2-3 2000 343 354
132. D. Ojkic, and E. Nagy The long repeat region is dispensable for fowl adenovirus replication in vitro Virology 283 2 2001 197 206
133. D. Ojkic, and E. Nagy Antibody response and virus tissue distribution in chickens inoculated with wild-type and recombinant fowl adenoviruses Vaccine 8 22 2003 42 48
134. M. Sheppard, W. Werner, E. Tsatas, R. McCoy, S. Prowse, and M. Johnson Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease Arch Virol 143 5 1998 915 930